Esperion Therapeutics reported $312.83M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amarin AMRN:US USD 908.3M 64.93M
Amgen AMGN:US USD 65.12B 1.42B
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Cytokinetics CYTK:US USD 1.08B 304.24M
Daiichi Sankyo 4568:JP JPY 2.4T 29.74B
Eli Lilly And LLY:US USD 47.46B 397.9M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Merk MRK:US USD 107.08B 14M
Minerva Neurosciences NERV:US USD 59.76M 5.2M
Moderna Inc MRNA:US USD 26.06B 13M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Puma Biotechnology PBYI:US USD 198.77M 5.12M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Seattle Genetics SGEN:US USD 3.62B 11.26M
United Therapeutics UTHR:US USD 5.78B 238.3M
Vanda Pharmaceuticals VNDA:US USD 621.79M 12.69M